PHB2 and neoplasm: Co-immunoprecipitation experiments in tumours indicated that treatment with stERAP-6 every 4 days, but not with unstapled original ERAP, led to effective inhibition of the endogenous BIG3-PHB2 complex formation (Fig. 3b).